Elizaveta L Hansen

2023

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Allesøe, R. L., Lundgaard, A. T., Hernández Medina, R., Aguayo-Orozco, A., Johansen, J., Nissen, J. N., Brorsson, C., Mazzoni, G., Niu, L., Biel, J. H., Brasas, V., Webel, H., Benros, M. E., Pedersen, A. G., Chmura, P. J., Jacobsen, U. P., Mari, A., Koivula, R., Mahajan, A. & Vinuela, A. & 32 others, Tajes, J. F., Sharma, S., Haid, M., Hong, M. G., Musholt, P. B., De Masi, F., Vogt, J., Pedersen, H. K., Gudmundsdottir, V., Jones, A., Kennedy, G., Bell, J., Thomas, E. L., Frost, G., Thomsen, H., Hansen, E., Hansen, T. H., Vestergaard, H., Muilwijk, M., Blom, M. T., ‘t Hart, L. M., Pattou, F., Raverdy, V., Brage, S., Kokkola, T., Heggie, A., McEvoy, D., Mourby, M., Kaye, J., Ridderstråle, M., IMI-DIRECT consortium & Engelbrechtsen, L. (Member of study group), Mar 2023, In: Nature Biotechnology. 41, 3, p. 399-408 10 p.

Research output: Contribution to journal › Journal article › Research › peer-review

32 Citations (Scopus)

Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models (vol 41, pg 399, 2023): Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x)

Allesøe, R. L., Lundgaard, A. T., Hernández Medina, R., Aguayo-Orozco, A., Johansen, J., Nissen, J. N., Brorsson, C., Mazzoni, G., Niu, L., Biel, J. H., Leal Rodríguez, C., Brasas, V., Webel, H., Benros, M. E., Pedersen, A. G., Chmura, P. J., Jacobsen, U. P., Mari, A., Koivula, R. & Mahajan, A. & 31 others, Vinuela, A., Tajes, J. F., Sharma, S., Haid, M., Hong, M.-G., Musholt, P. B., De Masi, F., Vogt, J., Pedersen, H. K., Gudmundsdottir, V., Jones, A., Kennedy, G., Bell, J., Thomas, E. L., Frost, G., Thomsen, H., Hansen, E., Hansen, T. H., Vestergaard, H., Muilwijk, M., Blom, M. T., 't Hart, L. M., Pattou, F., Raverdy, V., Brage, S., Ridderstråle, M., Pedersen, O., Hansen, T., Rasmussen, S., Brunak, S. & IMI-DIRECT consortium, Jul 2023, In: Nature Biotechnology. 41, 7, p. 1026 1 p.

Research output: Contribution to journal › Journal article › Research › peer-review

2018

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C. & Torekov, S. S., 1 Aug 2018, In: Cell Metabolism. 28, 1, p. 23-32

Research output: Contribution to journal › Journal article › Research › peer-review

96 Citations (Scopus)

Elizaveta L Hansen

Research output

Search results

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models (vol 41, pg 399, 2023): Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x)

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist